Inpremzia Unjoni Ewropea - Malti - EMA (European Medicines Agency)

inpremzia

baxter holding b.v. - insulin human (rdna) - diabetes mellitus - drogi użati fid-dijabete - inpremzia is indicated for the treatment of diabetes mellitus.

Velosulin Unjoni Ewropea - Malti - EMA (European Medicines Agency)

velosulin

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Insulatard Unjoni Ewropea - Malti - EMA (European Medicines Agency)

insulatard

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Protaphane Unjoni Ewropea - Malti - EMA (European Medicines Agency)

protaphane

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Actraphane Unjoni Ewropea - Malti - EMA (European Medicines Agency)

actraphane

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Mixtard Unjoni Ewropea - Malti - EMA (European Medicines Agency)

mixtard

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Insuman Unjoni Ewropea - Malti - EMA (European Medicines Agency)

insuman

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drogi użati fid-dijabete - dijabete mellitus fejn huwa meħtieġ it-trattament bl-insulina. insuman rapid huwa wkoll adattat għall-kura ta 'koma ipergliċemika u ketoaċidożi, kif ukoll għall-kisba ta' stabilizzazzjoni minn qabel, intra u wara l-operazzjoni f'pazjenti bid-dijabete mellitus.

Insulin aspart Sanofi Unjoni Ewropea - Malti - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Insulin Human Winthrop Unjoni Ewropea - Malti - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drogi użati fid-dijabete - dijabete mellitus fejn huwa meħtieġ it-trattament bl-insulina. insulina bniedem winthrop mgħaġġla huwa wkoll adattat għat-trattament ta ' koma hyperglycaemic u ketoacidosis, kif ukoll għall-kisba minn qabel, intra - u postoperative stabbilizzazzjoni fil-pazjenti bl-diabetes mellitus.

Insulin lispro Sanofi Unjoni Ewropea - Malti - EMA (European Medicines Agency)

insulin lispro sanofi

sanofi winthrop industrie - insulina lispro - diabetes mellitus - drogi użati fid-dijabete - għat-trattament ta 'adulti u tfal b'dijabete mellitus li jeħtieġu l-insulina għall-manteniment ta' omeostasi normali tal-glukożju. insulin lispro sanofi huwa indikat ukoll għall-istabbilizzazzjoni inizjali tad-dijabete mellitus.